BioUtah News
-
This plan to cut drug prices could result in lost jobs and fewer medicines
By Kelvyn Cullimore For the Deseret News
-
Myriad Genetics Advances Prostate Cancer Care with Addition of Absolute Risk Reduction to Prolaris®
Prolaris is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1
-
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported…
-
Utah Company Developing Origami-inspired Technology Awarded NSF Grant to Advance Robotic Surgery
August 7, 2023 Four years ago, Jacob Sheffield was building world-class carbon fiber travel guitars for adventurers journeying…
-
Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status
Myriad Genetics announced enhancements to the GeneSight® Psychotropic test.
-
Myriad Genetics and Intermountain Health Participate in ComboMATCH, a National Clinical Trial to Advance Cancer Treatment
ComboMATCH study uses genetic testing to match advanced cancer patients with targeted treatments
-
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
World leading, multi-disciplinary experts advise on adoption of FDA authorized KidneyintelX.dkd across 14 million US patients with diabetes…
-
Merit Medical’s WRAPSODY™ Arteriovenous Access Efficacy (WAVE) Pivotal Study Completes Enrollment
SOUTH JORDAN, Utah, Aug. 03, 2023 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global…
-
Alucent Biomedical Wins FDA Approval for U.S. Clinical Study
U.S. FDA Grants an Investigational Device Exemption for Trial Evaluating Novel AlucentNVS Technology
-
Quansys Biosciences and The Michael J. Fox Foundation Partner to Accelerate Parkinson’s Disease Research
Quansys Biosciences and The Michael J. Fox Foundation, announced a strategic partnership to accelerate research into PD.
-
Government Price Setting Would Lead to Lost Therapies, Innovation and Jobs in Utah
New Study Details Proposed Federal Government-Mandated Drug Pricing Policies Senate SMART Prices Act Will Cost More Than 235…
-
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research.…
-
DEVICE FOR TREATING CHALLENGING BONE FRACTURES CLEARED BY FDA
A new system for fixing bone fractures, called the Bone Bolt System, has been approved for market by…
-
Owlet Appoints Executive Jonathan Harris as New Company President and Chief Revenue Officer
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, today…
-
Myriad Genetics Announces Inclusion of Breast Density to MyRisk® with RiskScore® Breast Cancer Risk Assessment
RiskScore is the first validated risk model that includes breast density, personal/family history and genetic markers. This comprehensive…
-
BD Receives FDA 510(k) Clearance for Updated BD Alaris™ Infusion System
BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that…
-
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
Distribution agreement opens kidneyintelX.dkd testing to address early-stage kidney disease in region with one of the highest incidence…
-
Owlet Appoints Healthcare Executive Melissa Gonzales to Board of Directors
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT, “the Company”), the pioneer of smart baby monitoring, is pleased to…
-
Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program
The Company intends to use the funds awarded by the National Institutes of Health for completion of its…
-
Co-Diagnostics, Inc. Announces Recent Grant Awards
The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis…
-
ELEVAR THERAPEUTICS ANNOUNCES FDA ACCEPTANCE FOR FILING OF NEW DRUG APPLICATION FOR RIVOCERANIB IN COMBINATION WITH CAMRELIZUMAB AS A FIRST-LINE TREATMENT FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA
FORT LEE, NEW JERSEY, July 17, 2023 – Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd.…
-
Stuart Goldblatt Joins CenExel as CEO
Salt Lake City, July 17, 2023 /GlobeNewswire/ — The CenExel Board of Directors is delighted to announce that…
-
Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessions
12 Months KidneyIntelX™ in vitro prognostic testing continued to demonstrate clinical actions that lead to improvement in both…
-
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster SALT LAKE…
-
FDA Approves ARUP Laboratories’ AAV5 DetectCDx™, a First-Ever Companion Diagnostic Immunoassay for a Gene Therapy
SALT LAKE CITY—ARUP Laboratories today announced that the U.S. Food and Drug Administration (FDA) has approved AAV5 DetectCDx™…
-
IONIQ is “Best Diagnostic Testing Solution 2023”
Salt Lake City, UT, July 7, 2023 –Medtech Breakthrough has awarded IONIQ Sciences the “Best Diagnostic Testing Solution…
-
BioUtah Members Can Get Discounted Registration to the 2023 RESI conference
BioUtah partnered with Life Science Nation to get you the Super Early Bird prices to the largest early-stage…
-
Myriad Genetics Announces New $90 Million Asset-Based Credit Facility
SALT LAKE CITY, July 06, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
-
Renalytix Appoints Financial Executive Catherine Coste to its Board of Directors
LONDON and SALT LAKE CITY, July 03, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), the first company to…
-
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA
Three separate teams of physician scientists at UCLA working on three different parts of the project have made…
-
Ultradent Adds New Cordless Prophy Handpiece
Ultradent Products, Inc. is announcing the addition of the Ultrapro™ Tx Cordless handpiece to its prestigious Ultrapro™ Tx…
-
CLENE ANNOUNCES PUBLICATION OF PHASE 2 CNM-AU8® CLINICAL DATA FOR THE TREATMENT OF ALS IN LANCET’S ECLINICALMEDICINE
Peer-reviewed publication includes data from the CNM-Au8 Phase 2 RESCUE-ALS trial and its open-label-extension, up to 120 weeks…
-
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
-
Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray
Intermountain Health Opens New Outpatient Surgery Center on TOSH Campus in Murray
-
CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment
UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting Ewing sarcoma
-
FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions
On June 13, the U.S. Food and Drug Administration (FDA) issued the final guidance: Content of Premarket Submissions…
-
Denali Therapeutics, Alucent Biomedical, Present to Utah Life Sciences Innovation Caucus
Utah legislators on Wednesday, June 14, held a meeting of the Utah Life Sciences Innovation Caucus (ULSIC) at…
-
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
Recursion’s small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial…
-
Myriad Genetics Announces Research Collaboration to use Minimal Residual Disease Testing Platform
Myriad to support MD Anderson researchers studying metastatic renal cell carcinoma treatment selection and response
-
Merit Medical Announces Acquisition of Dialysis Catheter Portfolio and the BioSentry® Biopsy Tract Sealant System from AngioDynamics, Inc. and Acquisition of the Surfacer® Inside-Out® Access Catheter System from Bluegrass Vascular Technologies, Inc.
Acquisitions broaden Merit’s therapeutic platform with diverse dialysis product solutions and expand its access catheter offering Acquisitions projected…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
